Vitor Antunes Oliveira

Dr. Vitor Antunes Oliveira

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 July 2024 in Chemosphere
Verified
Journal Article
Closed access
LCLílian Corrêa Costa-Beber
Lílian Corrêa Costa-Beber
RMRafael Kazmirczak Moraes
Rafael Kazmirczak Moraes
JOJéssica Obelar
Jéssica Obelar
LMLeo Anderson Meira Martins
Leo Anderson Meira Martins
ATAna Laura Toquetto
Ana Laura Toquetto
FGFátima Theresinha Costa Rodrigues Guma
Fátima Theresinha Costa Rodrigues Guma

11 July 2024
Verified
Book Chapter
Open access
PDF file
EMEduardo Almeida de Souza Minuzzo
Eduardo Almeida de Souza Minuzzo
PFPauline Brendler Goettems Fiorin
Pauline Brendler Goettems Fiorin
VOVitor Antunes Oliveira
Vitor Antunes Oliveira
MLMirna Stela Ludwig
Mirna Stela Ludwig
MFMatias nunes Frizzo
Matias nunes Frizzo
The Intensive Care Unit (ICU) has the highest incidence of patients with various infectious processes. Sepsis, a systemic inflammatory response syndrome associated with infections, is characterized by inflammatory cytokine production, innate immune system activation, mitochondrial damage, and severe organ dysfunction. Early diagnosis is crucial for appropriate therapeutic interventions and reducing mortality. Various biomarkers have been studied for diagnostic and prognostic purposes, including lactate, interleukins, C-reactive protein, and procalcitonin. Immune-inflammatory biomarkers, such as leukogram, leukocyte ratios, neutrophil variation index, and leukocyte morphological parameters, provide valuable information about sepsis severity and progression. Additionally, redox state and cellular stress response biomarkers contribute to understanding sepsis pathophysiology and organ dysfunction stratification. The combined use of these biomarkers allows for more accurate diagnoses, early treatment, reduced hospital stays, minimized sequelae, and decreased sepsis mortality risk. This chapter describes the applicability of clinical and laboratory parameters as biomarkers for diagnosing and prognosing infectious processes and sepsis in ICU patients.

5 November 2022 in Toxics
Verified
Journal Article
Open access
PDF file
MGMaria Eduarda Andrade Galiciolli
Maria Eduarda Andrade Galiciolli
TPTaíse Fonseca Pedroso
Taíse Fonseca Pedroso
MFMariana Mesquita Fonseca
Mariana Mesquita Fonseca
VOVitor Antunes Oliveira
Vitor Antunes Oliveira
MPMaria E. Pereira
Maria E. Pereira
Cláudia Sirlene OliveiraCláudia Sirlene Oliveira
Cláudia Sirlene Oliveira
The aim of this study was to investigate the effects of inorganic mercury (Hg2+) exposure on biochemical parameters of dams and their offspring exposed to metal in drinking water. Female Wistar rats were exposed to 0, 10, and 50 µg Hg2+/mL (as HgCl2) for 42 days corresponding to gestational (21 days) and lactational (21 days) periods. The offspring were sacrificed on postnatal days 10, 20, 30, and 40. Dams exposed to Hg2+ presented a decrease in water intake in gestation [total: F(2,19) = 15.84; p ≤ 0.0001; daily: F(2,21) = 12.71; p = 0.0002] and lactation [total: F(2,19) = 4.619; p = 0.024; daily: F(2,21) = 5.309; p = 0.0136] without alteration in food intake. Dams exposed to 50 µg Hg2+/mL had an increase in kidney total [F(2,21) = 8.081; p = 0.0025] and relative [F(2,21) = 14.11; p = 0.0001] weight without changes in biochemical markers of nephrotoxicity. Moreover, dams had an increase in hepatic [F(2,10) = 3.847; p = 0.0577] and renal [F(2,11) = 6.267; p = 0.0152] metallothionein content concomitantly with an increase in renal Hg levels after Hg2+ exposure. Regarding offspring, the exposure to Hg2+ in utero and breast milk increased the relative liver [F(2,18) = 5.33; p = 0.0152] and kidney [F(2,18) = 3.819; p = 0.0415] weight only on the postnatal day 40. In conclusion, dams were able to handle the Hg2+ avoiding the classic Hg2+ toxic effects as well as protecting the offspring. We suggest that this protection is related to the hepatic and renal metallothionein content increase.

12 November 2019 in bioRxiv
Verified
Preprint
Open access
PDF file
EMEmerson Marins
Emerson Marins
JSJulia Spanhol da Silva
Julia Spanhol da Silva
PRPâmela Carvalho da Rosa
Pâmela Carvalho da Rosa
VOVitor Antunes Oliveira
Vitor Antunes Oliveira
APAline Zuanazzi Pasinato
Aline Zuanazzi Pasinato
RBRômulo Barcelos
Rômulo Barcelos
Caramel dye IV (C-IV) is a synthetic organic product, does not present nutritional, ergogenic, or technological factors, but leads to reactive oxygen species (ROS), causing damage to a wide range of molecules, leading to cancer, cardiovascular and neurodegenerative diseases development. We aimed to verify the effects of different doses of C-IV dye on the markers of oxidative stress in the liver and kidneys from male Swiss CF-1 mice, divided into 4 experimental groups: control; C-IV 0.3g/kg; C-IV 1g/kg and C-IV 3g/kg. We found that 3 g/Kg of C-IV dye promote oxidative damage in liver and kidney homogenates, evidenced by the increase of lipid peroxidation, reduction of free SH groups, and higher ROS production. As a consequence, increased superoxide dismutase and acetylcholinesterase enzymes activities were detected. These damages were confirmed through histology images. These results indicate that daily doses might induce oxidative stress damages and possible lead to chronic diseases development.

Verified
Journal Article
Open access
PDF file
MAMaria Eduarda Andretta
Maria Eduarda Andretta
MFMatias nunes Frizzo
Matias nunes Frizzo
PGPauline Brendler Goettems-Fiorin
Pauline Brendler Goettems-Fiorin
Thiago Gomes HeckThiago Gomes Heck
Thiago Gomes Heck
LSLucas Machado Sulzbacher
Lucas Machado Sulzbacher
VOVitor Antunes Oliveira
Vitor Antunes Oliveira
Coronavirus disease 2019 (COVID-19) has posed unprecedented challenges to global public health, highlighting the importance of prognostic biomarkers in critically ill patients. The oxidative stress developed in COVID-19 is associated with impairment in various human organs and systems, and it is related to erythrocyte injury, leading to an elevation in red cell distribution width (RDW) and systemic inflammation. This study aims to assess the prognostic value of erythrogram indicators and C-reactive protein (CRP) levels in 91 intensive care unit-admitted COVID-19 patients, categorized into survivor patients (discharge group) and non-survivor patients (death group). The results were presented using descriptive statistics and the Mann–Whitney test. The most severe cases of respiratory failure in which the patients did not survive showed higher red cell distribution width (RDW) and lower values of red blood cell count, hemoglobin, and hematocrit. RDW may be an important indicator of mortality, as demonstrated by the receiver operating characteristic (ROC) curve analysis. Furthermore, this increase in RDW is correlated with elevated CRP levels, another important clinical outcome for these patients. In conclusion, elevated RDW and CRP levels at admission may be reliable predictors of unfavorable outcomes, emphasizing the utility of these indicators in clinical assessments of COVID-19 patients.

17 February 2025 in Revista Contexto & Saúde
Verified
Journal Article
Open access
PDF file
GMGabriel Henrique Schmidt Mattos
Gabriel Henrique Schmidt Mattos
VVVitória de Oliveira Viland
Vitória de Oliveira Viland
MSMaicon Machado Machado Sulzbacher
Maicon Machado Machado Sulzbacher
VOVitor Antunes Oliveira
Vitor Antunes Oliveira
MFMatias nunes Frizzo
Matias nunes Frizzo
O vírus SARS-CoV-2, agente etiológico da coronavirus disease 2019 (COVID-19), infecta as células dos hospedeiros e inicia seu processo de replicação viral. Após o período de incubação viral, a doença pode desenvolver sintomas, que se manifestar desde sintomas gripais a formas graves (como a insuficiência respiratória), apresentando risco de vida. A resposta inflamatória exacerbada na COVID-19 é associada a alterações leucocitárias (contagem global e diferencial), plaquetárias, e proteína C reativa (PCR), que quando avaliadas de forma isoladas possuem menor capacidade indicativa do quadro clínico. No entanto as relações no hemograma como a Relação entre Linfócito e leucócitos Totais (RL/WBC) e Relação Plaqueta Linfócitos (RPL) podem inferir de forma assertiva o estado clínico imuno-inflamatório. O objetivo deste estudo foi avaliar se os parâmetros leucocitários podem ser utilizados como biomarcadores de prognóstico e desfecho em pacientes COVID-19 críticos. Participaram deste estudo 236 pacientes internados em UTI - COVID-19, de um hospital de médio porte e alta complexidade localizado no Noroeste do Estado do Rio Grande do Sul. Os parâmetros clínicos e laboratoriais avaliados foram a PCR, RL/WBC e RPL, que foram coletados na admissão e desfecho dos pacientes. Os dados foram expressos em média e desvio padrão, e analisados a partir do teste T de Student, considerado nível de significância de 5%. Identificamos a aplicabilidade dos biomarcadores PCR, RL/WBC e RPL como biomarcadores preditivos em pacientes críticos de COVID-19. Tanto as concentrações séricas de PCR, RL/WBC e RPL podem ser preditivos do desfecho, assim como indicam prognóstico de pacientes com COVID-19.